Richard Hague
2017 - Anika Therapeutics
In 2017, Richard Hague earned a total compensation of $1.1M as Chief Commerical Officer at Anika Therapeutics, a 17% decrease compared to previous year.
Compensation breakdown
Bonus | $102,698 |
---|---|
Option Awards | $599,331 |
Salary | $326,025 |
Other | $27,096 |
Total | $1,055,150 |
Hague received $599.3K in option awards, accounting for 57% of the total pay in 2017.
Hague also received $102.7K in bonus, $326K in salary and $27.1K in other compensation.
Rankings
In 2017, Richard Hague's compensation ranked 8,739th out of 14,666 executives tracked by ExecPay. In other words, Hague earned more than 40.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,739 | 40th |
Manufacturing | 3,330 | 42nd |
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 433 | 50th |
Surgical, Medical, And Dental Instruments And Supplies | 241 | 55th |
Surgical and Medical Instruments and Apparatus | 148 | 56th |
Hague's colleagues
We found six more compensation records of executives who worked with Richard Hague at Anika Therapeutics in 2017.
2017
Charles Sherwood
Anika Therapeutics
Chief Executive Officer
2017
Joseph Darling
Anika Therapeutics
President
2017
Sylvia Cheung
Anika Therapeutics
Chief Financial Officer
2017
Edward Ahn
Anika Therapeutics
Chief Technology and Strategy Officer
2017
Ed Ahn
Anika Therapeutics
Chief Technology and Strategy Officer
2017
Thomas Finnerty
Anika Therapeutics